Optimal timing of cardiac transplantation after ventricular assist device implantation

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 6, 2004, Pages 1789-1799

  Gammie, James S ^a   Edwards, Leah B ^b   Griffith, Bartley P ^a   Pierson III, Richard N ^a   Tsao, Lana ^c   Pagani, Francis D ^d   Frazier, O Howard ^d  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; FEMALE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURGICAL MORTALITY; SURVIVAL; SYSTEMATIC REVIEW;

EID: 2642557221     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.12.018     Document Type: Article

References (13)

1. John R, Lietz K, Schuster M, Naka Y, Rao V, Mancini DM, et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg. 2003;125:578-91.
2. Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol. 2002;39:1247-54.
3. Ashton RC Jr, Goldstein DJ, Rose EA, Weinberg AD, Levin HR, Oz MC. Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant. 1996;15:1151-7.
4. Jaski BE, Kim JC, Naftel DC, Jarcho J, Costanzo MR, Eisen HJ, et al. Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy. J Heart Lung Transplant. 2001;20:449-56.
5. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules: historical background and implications for transplantation management. United Network for Organ Sharing. J Heart Lung Transplant. 1999;18:1065-70.
6. Arriagada R, Rutqvist LE, Kramar A, Johansson H. Competing risks determining event-free survival in early breast cancer. Br J Cancer. 1992;66:951-7.
7. Kormos RL, Breen TJ, Frazier OH, Hosenpud JD. Sub-study analysis of ISHLT/UNOS Registry, Richmond, VA: use of ventricular assist devices before heart transplant effects of type of support on transplant survival. J Heart Lung Transplant. 1995;14(1:2):S67.
8. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: eighteenth official report - 2001. J Heart Lung Transplant. 2001;20:805-15.
9. Massad MG, McCarthy PM, Smedira NG, Cook DJ, Ratliff NB, Goormastic M, et al. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? J Thorac Cardiovasc Surg. 1996;112:1275-83.
10. UNOS/OPTN annual report. Available at: www.optn.org/data/ annualreport. Accessed 2003.
11. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-43.
12. Frazier OH, Macris MP, Myers TJ, Duncan JM, Radovancevic B, Parnis SM, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994;57:1416-22.
13. McCarthy PM, Savage RM, Fraser CD, Vargo R, James KB, Goormastic M, et al. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg. 1995;109:409-18.